The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.

April 22 (Reuters) - Amneal Pharmaceuticals has agreed to acquire biopharma firm Kashiv BioSciences in a cash-and-stock deal worth up to $1.1 billion that will expand the drugmaker's biosimilars ...

Novartis NOVN0.18%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to $2 billion, adding a new approach to treat allergic diseases to its immunology ...

Eli Lilly & Co. agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the weight-loss medication giant is looking to bulk up its treatment pipeline for ...

Gilead Sciences Inc. said it would acquire Ouro Medicines, a closely held company testing novel antibody drugs against autoimmune diseases, for as much as $2.18 billion. Under terms of the deal, ...

Neurocrine Biosciences NBIX-1.99%decrease; red down pointing triangle agreed to buy Soleno Therapeutics SLNO 0.02%increase; green up pointing triangle for $2.9 billion, giving it the first approved ...

Abivax's leading candidate looks very promising. However, between potential clinical setbacks and the biotech's high market cap, the stock looks risky. That said, with an upcoming catalyst and a ...

Some researchers are delighted at an executive order to streamline investigations of psychedelics but also warn that caution ...

What to do—and what not to do. If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight-loss ...

This story is the final part of CNN's As Equals series on gender inequality. For information about how the series was funded and more, check out our FAQs. The world was confronted by this form of ...

President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.